JP2017513826A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513826A5 JP2017513826A5 JP2016560695A JP2016560695A JP2017513826A5 JP 2017513826 A5 JP2017513826 A5 JP 2017513826A5 JP 2016560695 A JP2016560695 A JP 2016560695A JP 2016560695 A JP2016560695 A JP 2016560695A JP 2017513826 A5 JP2017513826 A5 JP 2017513826A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- group
- substituted
- composition
- aryl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461973994P | 2014-04-02 | 2014-04-02 | |
| US61/973,994 | 2014-04-02 | ||
| PCT/US2015/023883 WO2015153761A2 (en) | 2014-04-02 | 2015-04-01 | Macrocyclic peptidomimetics for alpha-helix mimicry |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017513826A JP2017513826A (ja) | 2017-06-01 |
| JP2017513826A5 true JP2017513826A5 (enExample) | 2018-05-17 |
| JP6642887B2 JP6642887B2 (ja) | 2020-02-12 |
Family
ID=54241434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016560695A Expired - Fee Related JP6642887B2 (ja) | 2014-04-02 | 2015-04-01 | アルファヘリックスを模倣した大環状ペプチドミメティック |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10294273B2 (enExample) |
| EP (1) | EP3126375B1 (enExample) |
| JP (1) | JP6642887B2 (enExample) |
| CN (1) | CN106604928A (enExample) |
| CA (1) | CA2944651A1 (enExample) |
| WO (1) | WO2015153761A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10827064B2 (en) | 2016-06-13 | 2020-11-03 | Google Llc | Automated call requests with status updates |
| KR102155763B1 (ko) | 2016-06-13 | 2020-09-16 | 구글 엘엘씨 | 인간 운영자로의 에스컬레이션 |
| WO2018227053A1 (en) * | 2017-06-09 | 2018-12-13 | Bristol-Myers Squibb Company | Non-chromatographic purification of macrocyclic peptides by a resin catch and release |
| US11524979B2 (en) | 2017-06-15 | 2022-12-13 | University Of Washington | Macrocyclic polypeptides |
| CA3078504A1 (en) | 2017-10-04 | 2019-04-11 | Ohio State Innovation Foundation | Bicyclic peptidyl inhibitors |
| CN111447941B (zh) * | 2017-10-27 | 2023-10-31 | 俄亥俄州国家创新基金会 | 用于细胞内递送装订肽的多肽缀合物 |
| US11793884B2 (en) | 2018-01-29 | 2023-10-24 | Ohio State Innovation Foundation | Cyclic peptidyl inhibitors of CAL-PDZ binding domain |
| US11987647B2 (en) | 2018-05-09 | 2024-05-21 | Ohio State Innovation Foundation | Cyclic cell-penetrating peptides with one or more hydrophobic residues |
| EP4661382A2 (en) | 2019-05-06 | 2025-12-10 | Google Llc | Automated calling system |
| US11158321B2 (en) | 2019-09-24 | 2021-10-26 | Google Llc | Automated calling system |
| EP3909230B1 (en) | 2020-03-20 | 2024-10-23 | Google LLC | Semi-delegated calling by an automated assistant on behalf of human participant |
| US11303749B1 (en) | 2020-10-06 | 2022-04-12 | Google Llc | Automatic navigation of an interactive voice response (IVR) tree on behalf of human user(s) |
| WO2023107353A2 (en) * | 2021-12-10 | 2023-06-15 | Merck Sharp & Dohme Llc | P53 peptidomimetic macrocycles |
| TW202417465A (zh) | 2022-08-23 | 2024-05-01 | 日商富士軟片股份有限公司 | 環肽或其鹽及ｍｄｍｘ抑制劑 |
| WO2024054892A1 (en) * | 2022-09-09 | 2024-03-14 | Shape Therapeutics Inc. | Therapeutic peptides |
| US12225158B2 (en) | 2022-12-15 | 2025-02-11 | Google Llc | System(s) and method(s) for implementing a personalized chatbot |
| KR20250134670A (ko) | 2023-01-16 | 2025-09-11 | 암브룩스, 인코포레이티드 | 항-cd70 항체-약물 접합체 |
| US12581015B2 (en) | 2023-03-21 | 2026-03-17 | Google Llc | Automating telephone call(s) on behalf of user(s) |
| AR131133A1 (es) | 2023-05-24 | 2025-02-19 | Ambrx Inc | INTERFERÓN l BOVINO PEGILADO Y MÉTODOS DE USO DEL MISMO |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7083983B2 (en) | 1996-07-05 | 2006-08-01 | Cancer Research Campaign Technology Limited | Inhibitors of the interaction between P53 and MDM2 |
| US8193310B2 (en) * | 2004-03-19 | 2012-06-05 | The University Of Queensland | Alpha helical mimics, their uses and methods for their production |
| US7960506B2 (en) * | 2006-12-14 | 2011-06-14 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
| EP2242503A4 (en) * | 2008-02-08 | 2012-04-25 | Aileron Therapeutics Inc | THERAPEUTIC PEPTIDOMIMETIC MACROCYCLES |
| US8343760B2 (en) * | 2008-06-05 | 2013-01-01 | University Of Maryland, Baltimore | p53 activator peptides |
| JP2012503025A (ja) * | 2008-09-22 | 2012-02-02 | エルロン・セラピューティクス・インコーポレイテッド | 精製されたポリペプチド組成物を調製するための方法 |
| JP2012515172A (ja) * | 2009-01-14 | 2012-07-05 | エルロン・セラピューティクス・インコーポレイテッド | ペプチド模倣大環状分子 |
| WO2011038049A1 (en) * | 2009-09-22 | 2011-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| KR20130099938A (ko) * | 2010-08-13 | 2013-09-06 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| US9029332B2 (en) * | 2010-12-15 | 2015-05-12 | The Research Foundation For The State University Of New York | Cross-linked peptides and proteins, methods of making same, and uses thereof |
| US8986953B2 (en) * | 2011-01-20 | 2015-03-24 | University Of Rochester | Macrocyclic compounds with a hybrid peptidic/non-peptidic backbone and methods for their preparation |
-
2015
- 2015-04-01 EP EP15773413.8A patent/EP3126375B1/en active Active
- 2015-04-01 US US15/301,084 patent/US10294273B2/en active Active
- 2015-04-01 CA CA2944651A patent/CA2944651A1/en not_active Abandoned
- 2015-04-01 CN CN201580029301.XA patent/CN106604928A/zh active Pending
- 2015-04-01 JP JP2016560695A patent/JP6642887B2/ja not_active Expired - Fee Related
- 2015-04-01 WO PCT/US2015/023883 patent/WO2015153761A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017513826A5 (enExample) | ||
| ES2387685T3 (es) | Péptido WT1 restringido por HLA-A*3303 y composición farmacéutica que comprende el mismo | |
| RU2018131636A (ru) | Новые конъюгаты аманитина | |
| US20160264636A1 (en) | Peptide inhibitors of tead/yap-taz interaction | |
| JP2017006120A5 (enExample) | ||
| CY1117437T1 (el) | Αντισωματα αντι-μεσοθηλινης και χρησεις αυτων | |
| RU2007136026A (ru) | Варианты ил-21 | |
| JP2019501141A5 (enExample) | ||
| EA201891681A1 (ru) | Новая иммуностимулирующая векторная система | |
| MX2020000413A (es) | Una vacuna universal basada en neoantigenos de tumor compartidos para prevencion y tratamiento de canceres inestables de microsatelite (msi). | |
| JP2015522264A5 (enExample) | ||
| WO2020022898A3 (en) | Off-the-shelf cancer vaccines | |
| JP2017533728A (ja) | トランスフェリン受容体（ｔｆｒ）に対するｒｎａアプタマー | |
| NZ723940A (en) | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents | |
| JP2018507689A5 (enExample) | ||
| BR112012025567A2 (pt) | peptídeos de cdca5 e vacinas que incluem os mesmos | |
| CA2432971A1 (en) | Polypeptides | |
| RU2013108262A (ru) | Новые пептиды с анальгетическим эффектом, ингибирующие asic-rfyfks | |
| FI3335725T3 (fi) | Pds5a-epitooppeja immuuniteetin indusoijina | |
| CN108452322A (zh) | 基于长链非编码rna的bcl2基因抑制剂 | |
| CN112739381A (zh) | 使用了hsp47的抑制物质的癌转移抑制 | |
| AR113982A1 (es) | Péptido antagonista de la actividad de la interleucina-15 | |
| MX2012011385A (es) | Peptidos ect2 y vacunas que los incluyen. | |
| AR128014A1 (es) | Polipéptidos de penetración celular (cpp) y su uso en terapia humana | |
| EP2545171A4 (en) | HJURP PEPTIDES AND VACCINES CONTAINING THEM |